All Updates

All Updates

icon
Filter
Funding
Rgenta Therapeutics raises USD 52 million in a Series A funding
Precision Medicine
Nov 29, 2022
This week:
Product updates
Burcon unveils canola protein isolate for egg replacement
Plant-based Dairy & Egg
Yesterday
Product updates
Bene Meat Technologies produces first cultivated burger at parity with premium beef
Cell-cultured Meat
Yesterday
Geographic expansion
Regulation/policy
The Better Meat Co. expands to Asia with Singapore approval for Rhiza mycoprotein
Plant-based Meat
Yesterday
Listing
Pony.ai files for US IPO
Auto Tech
Yesterday
Product updates
MineOS launches DSR management 2.0
Digital Privacy Tools
Yesterday
Product updates
LatticeFlow launches the first evaluation framework for EU AI Act compliance
Generative AI Infrastructure
Yesterday
Product updates
Cognitive3D launches custom dashboards for XR analytics
Extended Reality
Oct 16, 2024
Funding
Mindtech raises GBP 4.4 million in funding to develop AI vision technology
Extended Reality
Oct 16, 2024
Partnerships
Zscaler and Okta partner to enhance zero trust security initiatives
Identity & Access Management
Oct 16, 2024
Partnerships
Zscaler and Okta partner to enhance zero trust security initiatives
Next-gen Cybersecurity
Oct 16, 2024
Precision Medicine

Precision Medicine

Nov 29, 2022

Rgenta Therapeutics raises USD 52 million in a Series A funding

Funding

  • Biotechnology start-up Rgenta Therapeutics raised USD 52 million in a Series A funding round led by AZ-CICC Healthcare Investment Fund, with participation from existing investors and new investors. This brings the total funds raised by the company to USD 108.9 million. 

  • The new funds will be used to advance its lead programs and pipeline of ribonucleic acid (RNA) programs, enhance target discovery, and expand its platform capabilities. 

  • Rgenta Therapeutics is focused on discovering and developing small-molecule drugs targeting RNAs to treat oncology and neurological disorders. The company’s proprietary drug discovery platform analyzes large genomic data to identify small molecule glues that target RNAs to regulate or alter protein production and functions.  

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.